Cargando…
P1255: TUMOR-ASSOCIATED MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS IS A POTENTIAL PROGNOSTIC BIOMARKER, PROMOTING MULTI-DRUG RESISTANCE IN NHL PATIENTS BY MODULATING IL-6/IL-10/IL-1Β AXIS
Autores principales: | Dhar, S., Chakravarti, M., Bera, S., Ganguly, N., Dasgupta, S., Sarkar, A., Saha, A., Banerjee, S., Saha, B., Baral, R., Mukherjee, K. K., Bose, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430059/ http://dx.doi.org/10.1097/01.HS9.0000847884.85697.8b |
Ejemplares similares
-
Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes
por: Achmus, Lennart, et al.
Publicado: (2020) -
Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes
por: Petes, Carlene, et al.
Publicado: (2018) -
Monocytic Myeloid-Derived Suppressor Cells Inhibit Myofibroblastic Differentiation in Mesenchymal Stem Cells Through IL-15 Secretion
por: Cheuk, Yin Celeste, et al.
Publicado: (2022) -
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
por: Tobin, Richard P., et al.
Publicado: (2019) -
IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells
por: Kulkarni, Upasana, et al.
Publicado: (2018)